جست‌وجوی استاد و پژوهشگر

Mark Morrisonمشاهده پروفایل

استاد مدعو

• Biomedical and Clinical Sciences
• Clinical microbiology
• Gastroenterology and hepatology
• +۳ مورد دیگر

Professor Mark Morrison is an Affiliate Professor at the School of Chemistry and Molecular Biosciences, University of Queensland, and holds roles as Chair & Group Leader of Metagenomics at the Frazer Institute within the Faculty of Health, Medicine and Behavioural Sciences. His research focuses on clinical microbiology, gastroenterology, and the microbiome’s role in diseases like inflammatory bowel disease (IBD) and diabetes. He has extensive academic qualifications, including a Bachelor of Science from the University of New South Wales, a Master’s from James Cook University, and a PhD from the University of Illinois. Education : Bachelor of Science, University of New South Wales Masters (Research) of Science, James Cook University Doctor of Philosophy, University of Illinois His research interests span microbiome-driven health and disease mechanisms, particularly in gut-brain interactions, mucosal microbiota dynamics, and translational therapies. Over 390 works include studies on dietary FODMAP effects, microbiome-based IBD diagnostics, and SCFA therapy for diabetes. He leads interdisciplinary grants on microbiome manipulation and has advised numerous PhD students on topics like Crohn’s disease, archaeal biodiversity, and immune modulation. His recent articles highlight microbiota roles in SIBO, anastomotic leaks, and probiotic efficacy. While no explicit awards are cited, his contributions to gut microbiome science are recognized through active research collaborations and funding. He actively supervises students and chairs teams advancing metagenomics and clinical applications.

• T cell immunology
• Immune tolerance
• Checkpoint inhibitor immunotherapy
• +۵ مورد دیگر

Martina Damo serves as Assistant Professor in the Department of Medicine, Section of Rheumatology at the University of Chicago School of Medicine, where she joined the faculty in October 2023. She leads a research laboratory investigating immune checkpoint receptors on T cells and their role in immunological tolerance, with particular focus on how checkpoint blockade immunotherapy causes immune-related adverse events (irAEs) in cancer patients. Her work aims to identify druggable tolerance pathways and develop bioengineered therapies for tolerance modulation. Dr. Damo's educational background includes: PhD in Bioengineering from Swiss Federal Institute of Technology in Lausanne (EPFL), 2016 Postdoctoral Fellowship in Immunobiology at Yale University, 2022 Instructor position at Yale University, 2023 Her research centers on T cell immunology in physiological and pathological contexts, with emphasis on peripheral tissue immunity. She investigates mechanisms of immune tolerance in skin and liver environments, neoantigen recognition by T cells, and the pathogenesis of irAEs following cancer immunotherapy. Her laboratory employs advanced techniques including clonal lineage tracing, mouse models of cancer and autoimmunity, and bioengineering approaches for therapeutic development. Analysis of her publication history (2011-2025) reveals an evolving research trajectory from foundational work in antigen-specific tolerance and gene therapy (2011-2015) to contemporary focus on T cell exhaustion, checkpoint biology, and cancer immunotherapy applications (2018-2025). Her most cited works involve CD8+ T cell dynamics in tumors and viral infections, with consistent emphasis on translational applications. Key thematic areas include T cell tolerance mechanisms, irAE pathogenesis, and bioengineered tolerance-inducing therapeutics. Dr. Damo actively mentors within her research laboratory and collaborates extensively with immunology researchers including Jeffrey Hubbell, Thomas Gajewski, and Melody Swartz. Her work has attracted significant attention with multiple publications exceeding 100 citations, substantial social media engagement (over 250 X posts), and patent references (23 patents citing her work). She maintains active research funding supporting her laboratory's investigations into T cell tolerance pathways. Her laboratory operates within the University of Chicago's immunology research ecosystem, collaborating with colleagues in the Department of Medicine including Maria-Luisa Alegre and James Curran. Current projects focus on developing targeted approaches to prevent irAEs while preserving anti-tumor efficacy of checkpoint inhibitors, leveraging her expertise in tissue-specific immune regulation.

Thomas Papمشاهده پروفایل

استاد

• Rheumatology
• Inflammation
• Arthritis
• +۴ مورد دیگر

Thomas Pap serves as Professor at the Department of Molecular Medicine within the Institute of Musculoskeletal Medicine (IMM) at the University of Muenster. He actively participates in the "Cells in Motion" research cluster and the Imaging Network, focusing on cell dynamics and imaging applications in musculoskeletal pathologies. His research centers on molecular mechanisms of inflammatory joint diseases, with key emphases on: Destructive arthritis pathogenesis through fibroblast transformation and adherens junction dynamics Regulation of alarmin activity (S100A8/S100A9) in sterile inflammation TRP channel modulation of osteoclast function and bone loss Translational models for tendon healing and microsurgical reconstruction Advanced imaging techniques for monitoring inflammatory lesions Analysis of his 2013-2021 publications reveals consistent interdisciplinary work bridging immunology, cell biology, and clinical applications. His studies frequently employ molecular imaging and translational models to investigate rheumatoid arthritis mechanisms, neutrophil chemotaxis, and bacterial immune evasion, with strong emphasis on therapeutic targeting of inflammatory pathways. The Pap Group operates within the Multiscale Imaging Centre (MIC), collaborating on pilot projects and the "Train Gain Fellowships" graduate program. Their work integrates with the university's broader Imaging Network, utilizing advanced microscopy and molecular techniques to study cell dynamics in inflammatory conditions.

Vivian Liمشاهده پروفایل

استاد پژوهشی

• Stem Cells
• Tumour Biology
• Developmental Biology
• +۶ مورد دیگر

Vivian Li is a Senior Group Leader and Assistant Research Director at The Francis Crick Institute in London, UK, leading a research group focused on intestinal stem cell biology and colorectal cancer mechanisms. Dr. Li earned her PhD from the University of Hong Kong's Department of Pathology in 2008, researching molecular mechanisms of human colonic development and tumorigenesis, for which she received the Gold Medal Prize. She then completed postdoctoral training with Hans Clevers at the Hubrecht Institute in the Netherlands, funded by the Croucher Foundation Fellowship, focusing on Wnt pathway proteomics and intestinal stem cell genes using transgenic mouse models. Her research program investigates how stem cells maintain healthy gut tissue and what goes wrong during cancer development, with particular emphasis on Wnt signaling pathways. Dr. Li's laboratory utilizes advanced organoid technology ('mini-guts') to study stem cell behavior in three-dimensional cultures, gene editing techniques, and state-of-the-art imaging approaches. Her work spans developmental biology, stem cell research, and cancer biology with significant translational implications. Analysis of her recent publications (2022-2025) reveals a strong focus on cancer stemness mechanisms, intestinal regeneration pathways, Wnt signaling components, and innovative organoid modeling approaches for colorectal cancer. Her research consistently bridges basic science with potential clinical applications in gastrointestinal medicine. Gold Medal Prize for PhD thesis Croucher Foundation Fellowship Dr. Li established her independent laboratory at the MRC National Institute for Medical Research in February 2013 and transitioned to the Francis Crick Institute in 2015. Her research aims to develop tumor-specific therapies for bowel cancer and grow replacement human gut tissue for transplantation or drug testing platforms. She leads a multidisciplinary team utilizing cutting-edge techniques including reverse mouse genetics, ex vivo organoid cultures, and advanced genomic and proteomic analyses to investigate stem cell regulation in health and disease. Her laboratory at the Crick Institute operates within the Biological Research Facility and collaborates extensively with other research groups both within the institute and internationally, contributing significantly to understanding intestinal stem cell niche dynamics and cancer development mechanisms.

Yuuki Obataمشاهده پروفایل

استادیار

• Gut Microbiota Research
• Immune System Regulation
• Enteric Nervous System Development
• +۳ مورد دیگر

Dr. Yuuki Obata is an Assistant Professor in the Department of Immunology and Neuroscience at UT Southwestern Medical Center, USA. He holds an Investigator role at the O'Donnell Brain Institute. Previously, he served as a postdoctoral fellow at the Francis Crick Institute (2016-2021) and the University of Tokyo (2015-2016). His research focuses on how environmental signals (microbiota, diet, circadian rhythms) shape intestinal neural circuits and immune networks. He employs advanced techniques including imaging, viral tracing, gnotobiotic systems, and multi-omics approaches. Education: PhD in Immunology from Chiba University (RIKEN Joint Graduate School Program), Japan. Postdoctoral training included JSPS Superlative Postdoctoral Fellowships (Japan) and EMBO/HFSP fellowships (UK). Research interests span microbiota-immune interactions, enteric nervous system development, gut-brain axis communication, and epigenetic regulation of immune responses. His lab investigates mechanisms linking microbial metabolites to host physiology, particularly in metabolic and neural contexts. Key findings include microbiota's role in IgA responses, T cell differentiation, and neuronal programming. Collaborations emphasize inter-organ communication and translational applications in immunology and neuroscience. Laboratory: The Obata Lab at UT Southwestern employs interdisciplinary methods to address how environmental factors reprogram gut neural and immune systems. Future work includes exploring microbiota-based therapies and neuroimmune interactions in disease models.

Derek Mark McKayمشاهده پروفایل

استاد

• Intestinal Physiology
• Gastrointestinal Immunology
• Inflammatory Bowel Disease (IBD)
• +۷ مورد دیگر

Derek Mark McKay is a Professor at the Cumming School of Medicine , University of Calgary , and holds the Lloyd Sutherland Professorship in IBD/GI Research . He directs the Snyder Institute for Chronic Diseases and is a full member of several academic networks, including the Inflammation Research Network and Gastrointestinal Research Group . Educational Background: BSc in Zoology, Queen's University of Belfast (1987) PhD in Zoology, Queen's University of Belfast (1990) His research focuses on intestinal physiology and immunity in health and disease , particularly: (1) the role of microbiota, immune mediators, and mitochondria in regulating epithelial barrier function, and (2) using helminth-rodent models to study immunomodulation pathways. His work is supported by major funders like CIHR , NSERC , Crohn’s Colitis Canada , and the Helmsley Charitable Trust . Scientific Awards: Honorary Doctor of Medicine, Linkoping University, Sweden (2022) Crohn's and Colitis Canada's Finkelstein Award (2021) Fellow, Canadian Academy of Health Sciences (2020) Canada Research Chair (Tier 1) (2006-2020) Fellow, American Association of Physiology (2020) C.P. Read Mentorship Award, American Society for Parasitology (2020) Fellow, Canadian Association of Gastroenterology (2016) Research Excellence Award, Canadian Association of Gastroenterology (2009) Stoll-Stunkard Memorial Lecture (2008) McKay has supervised 38 undergraduate students, 12 M.Sc., 11 Ph.D., and 15 post-doctoral fellows , including current advisees like Vickie Li (PhD candidate) and Armaan Mohan (PhD student). His lab includes key members like Arthur Wang (Lab Manager).

Karl-Heinz Wagnerمشاهده پروفایل

استاد

• Oxidative stress and DNA stability
• Molecular nutrition and phytochemicals
• Dietary antioxidants and aging
• +۵ مورد دیگر

Karl-Heinz Wagner is Full Professor of Nutrition and Food Quality at the University of Vienna, Faculty of Life Sciences, Department of Nutritional Sciences. He directs an experimental research group investigating how lifestyle factors—diet, specific food components, phytochemicals, physical activity and bioactive non-food compounds—modulate oxidative stress and DNA stability in humans, with emphasis on aging and sarcopenia. He initiated the university-wide “Active Ageing” research platform and coordinates EU projects such as SHIFT2HEALTH. Education & Affiliations: University of Vienna, Faculty of Life Sciences, Department of Nutritional Sciences – Professor and Chair of Nutrition and Food Quality Principal investigator of the Emerging Field “Oxidative Stress and DNA Stability” Head of the “Active Ageing” research platform activeageing.univie.ac.at Research Focus: Prof. Wagner’s group applies state-of-the-art biochemical and molecular techniques to quantify antioxidant compounds, ROS-induced DNA and chromosomal damage, DNA repair capacity and transcriptional regulation of antioxidant defenses. Human intervention trials, cross-sectional cohorts and in-vitro models are used to examine: Impact of plant-based vs. animal-based diets on multimorbidity risk Nitrate-rich beetroot juice effects on microbiome, vascular function and oxidative stress Bilirubin biology and metabolic health in Gilbert’s syndrome High-protein nutrition and resistance training on DNA damage and muscle quality in older adults Microbiota-derived metabolites that enhance CD8 T-cell antitumor immunity after exercise Publication Trends 2023-2025: Recent output demonstrates a strategic shift toward multi-omics integration (metabolomics, lipidomics, proteomics) to dissect diet–microbiome–immune crosstalk and to identify predictive biomarkers of healthy ageing. Papers consistently appear in top-tier journals (Cell, Lancet Healthy Longev, Redox Biol, Mol Nutr Food Res) and embrace large multinational cohorts, randomized controlled trials and mechanistic animal/cellular work. Funding & Networks: Research is mainly funded by the Austrian Science Fund (FWF), National Bank, European Commission (Horizon 2020, Horizon Europe), EU Cross-Border Co-operation and the University of Vienna. A dense national and international partner network ensures continuous biomarker development and knowledge transfer. Student Training & Citizen Science: Prof. Wagner actively involves MSc/PhD students and post-docs in externally funded projects and advertises internships via ERASMUS+. Study participant recruitment portals for projects like SHIFT2HEALTH, NUTRIAGING and bilirubin clinical studies are maintained to engage the public and foster translational impact.

Virginia Pedicordمشاهده پروفایل

استادیار

• Immunology
• Microbiota
• Host-Pathogen Interaction
• +۴ مورد دیگر

Dr. Virginia Pedicord is a Principal Investigator at the University of Cambridge's Department of Medicine and the Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID). She leads the Pedicord Lab within the Cambridge Immunology Network as a Sir Henry Dale Fellow, a prestigious research fellowship jointly funded by the Royal Society and Wellcome Trust. Her research focuses on understanding the complex interactions between gut microbiota, host immunity, and disease pathogenesis. Dr. Pedicord received her PhD in Immunology and Microbial Pathogenesis from Cornell University under the supervision of Dr. James P. Allison at Memorial Sloan Kettering Cancer Center, where she studied CD8+ T cell biology. She completed her postdoctoral training at the Rockefeller University before joining the University of Cambridge in 2018. Her laboratory employs a multi-disciplinary approach combining functional metagenomics, in vivo models, cellular immunology, transcriptomics, and proteomics to investigate how commensal microbes influence host intestinal and systemic physiology. Research focuses on gut microbiota's role in immune responses and pathogen resistance Investigates how gut microbes and microbial metabolites affect resistance to infection Studies local and systemic T cell responses and gut-brain axis of neuronal function Uses functional metagenomics to identify cellular and molecular targets of microbiota-mediated immunity Dr. Pedicord's recent publications demonstrate a strong focus on how specific gut bacteria like Enterocloster clostridioformis protect against pathogens such as Salmonella, how microbial metabolites enhance cancer immunotherapy, and the role of the microbiome in various disease contexts including pancreatic cancer and inflammatory bowel disease. Her work bridges fundamental microbiome research with potential therapeutic applications. Scientific Recognition: Sir Henry Dale Fellow (2018) Dr. Pedicord's research program aims to provide mechanistic insights into host-microbiota interactions that will advance our understanding of infectious diseases, autoimmune disorders, and cancer, potentially enabling new therapeutic approaches. Her laboratory is situated at the Jeffrey Cheah Biomedical Centre on the Cambridge Biomedical Campus.

Natalia Imad Khalafمشاهده پروفایل

استادیار

• Pancreatic Cancer
• Gastroenterology
• Epidemiology
• +۳ مورد دیگر

Natalia Imad Khalaf, MD, MPH, FACP is an Assistant Professor in the Department of Medicine at Baylor College of Medicine with dual appointments as Clinical Investigator in the Clinical Effectiveness and Population Health Program and Core Faculty in the Health Policy, Quality & Informatics Program at the Center for Innovations in Quality, Effectiveness and Safety (IQuESt) at Michael E. DeBakey VA Medical Center. Her academic trajectory spans clinical gastroenterology, epidemiology, and health services research with focus on cancer outcomes. Her educational foundation includes: BA in Biological Sciences from Rice University (2007) MD from Baylor College of Medicine (2011) Internal Medicine Residency and Chief Medical Residency at Baylor College of Medicine (2014-2015) Gastroenterology & Hepatology Fellowship at Brigham and Women's Hospital (2018) MPH in Epidemiology from Harvard T.H. Chan School of Public Health (2018) Dr. Khalaf's research program centers on pancreatic cancer epidemiology, with emphasis on early detection biomarkers (particularly new-onset diabetes), metabolic risk factors, and healthcare system interventions. Her work integrates clinical gastroenterology with population health methodologies to address diagnostic delays, racial disparities in treatment, and implementation of evidence-based guidelines in gastrointestinal cancers. She actively develops risk prediction tools using health informatics and deep learning approaches. Analysis of her recent publications reveals a concentrated focus on pancreatic cancer pathophysiology and outcomes, with significant contributions to understanding pre-diagnostic metabolic changes, emergency presentation consequences, and diabetes-cancer linkages. Her colorectal cancer work examines screening adherence barriers and medication risk associations, while quality improvement research targets guideline implementation for gastric intestinal metaplasia. Her scientific recognition includes: AGA Academy of Educators Elected Member (2018) Bob Parsons Inaugural Fellow in Pancreatic Cancer Research (2017-2018) American Gastroenterological Association Early Career Investigator Recognition (2017) Soma Weiss Award for Clinical Teaching Excellence (2017) Dean of Medical Education Outstanding Resident Teacher Award (2013) Phi Beta Kappa Honor Society (2007) Dr. Khalaf directs multiple federally funded research initiatives including: VA Career Development Award: Health Informatics Approaches to Improve Early Diagnosis of Pancreatic Cancer ($1.09M, 2022-2026) National Academy of Sciences: Clinical Quality Measures for Gastrointestinal Cancers (2022-2027) Gordon and Betty Moore Foundation: Implementing Digital Quality Measures (2024-2025) American Pancreatic Association Young Investigator Grant (2019-2021) She operates within the IQuESt research ecosystem at the Michael E. DeBakey VA, leveraging the Clinical Effectiveness and Population Health Program infrastructure for her work on cancer diagnostic excellence, veteran health outcomes, and implementation science projects targeting gastrointestinal cancer care pathways.

Gary H. Perdewمشاهده پروفایل

استاد

• Biochemistry
• Molecular Toxicology
• Carcinogenesis
• +۳ مورد دیگر

Gary H. Perdew is the H. Thomas & Dorothy Willits Hallowell Chair of Agricultural Sciences and Director of the Center for Molecular Toxicology and Carcinogenesis at Penn State University. He holds a B.S. in Food Science from the University of Maryland, M.S. in Food Biochemistry from Oregon State University, and a Ph.D. in Food Toxicology from Oregon State University, followed by postdoctoral training at the University of Wisconsin. His research focuses on the Aryl hydrocarbon receptor (AHR), exploring its role in toxicology, carcinogenesis, and metabolic regulation, particularly in barrier tissues like the intestine and skin. His work has led to collaborations with pharmaceutical companies developing AHR-targeted therapies. Key honors include the NIH R35 RIVER Outstanding Investigator Award (2019–2025), Penn State Faculty Scholar Medal (2002), and Distinguished Professor title (2004–2006). He teaches BMB 433: Biochemical and Molecular Toxicology and serves on NIH study sections. His lab investigates AHR’s dual role in cancer progression and immune modulation, aiming to develop treatments for inflammatory diseases and cancer. Ongoing projects include AHR antagonists in clinical trials and microbiome interactions with xenobiotic responses. Perdew’s research bridges environmental toxicology, cancer biology, and translational medicine, with over 150 publications and an impact index of 65. His lab also explores AHR’s role in metabolic homeostasis, gut microbiota dynamics, and evolutionary differences in receptor function across species.

Finn-Eirik Johansenمشاهده پروفایل

استاد

• Immunology
• Molecular Biology
• Comparative Immunology
• +۷ مورد دیگر

Professor Finn-Eirik Johansen is affiliated with the University of Oslo at the Department of Biosciences (IBV) . He previously served as head of department at IBV and held leadership roles at the Center for Immunoregulation (CIR), UiO:Life Sciences, and the Faculty of Mathematics and Natural Sciences. His research focuses on comparative immunology , particularly the unique immune system of Atlantic cod and its genetic adaptations. PhD in molecular biology from Columbia University Professor at UiO since 2013 Director of UiO:Life Sciences (2016-2017) Dean of research at the Faculty of Mathematics and Natural Sciences (2017-2019) His research spans mucosal immunity , secretory immunoglobulin systems , and teleost immunology . Recent work explores genetic deficiencies in immune receptors and their compensatory mechanisms in fish. Articles highlight IgA transport , CRISPR-based genome editing in cod , and mucosal lymphoid structures in zebrafish . Teaching includes immunology at master/PhD level and molecular/cell biology for undergraduates . He co-initiated the iGEM master’s course and Norway’s participation in the International Biology Olympiad . Current work integrates synthetic biology and marine immunology .

Scott Napperمشاهده پروفایل

استاد

• Vaccine Development
• Prion Diseases
• Kinome Analysis
• +۳ مورد دیگر

Dr. Scott Napper is a Professor in the Department of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, with a concurrent appointment as Senior Scientist at VIDO-Intervac. His work bridges structural biochemistry and immunology to address challenges in protein misfolding diseases, vaccine development, and host-pathogen signaling. Ph.D., Department of Biochemistry, 1999, University of Saskatchewan B.Sc. Honours, Department of Biochemistry, 1994, University of Saskatchewan Dr. Napper's research focuses on: Vaccine development for prion diseases and proteinopathies Kinome analysis for infectious disease mechanisms Peptide array technology for high-throughput signaling studies Science education outreach to secondary and undergraduate students Recent publications highlight his work in: Prion disease immunization strategies Host kinome responses to prebiotics Epitope immunogenicity prediction Comparative stress response analysis in livestock Scientific recognition includes: Three-time recipient of University of Saskatchewan Teaching Excellence Award His research program integrates computational approaches with experimental validation to identify therapeutic targets in: Infectious diseases of humans and animals Cancer signaling pathways Protein misfolding disorders Food contaminant toxicity

Maria L. Marcoمشاهده پروفایل

استاد

• Food Microbiology
• Gut Microbiome
• Probiotics & Fermented Foods
• +۳ مورد دیگر

Maria L. Marco is a Professor and Chair of the Food Science Graduate Group at the University of California, Davis. She holds a PhD in Microbial Biology (UC Berkeley, 1999) and a B.S. in Microbiology (Penn State, 1993). Her research focuses on microbial roles in fermented foods and gut health, emphasizing lactic acid bacteria's contributions to food production and human health. She teaches FST104 (Food Microbiology) and FST204 (Advanced Food Microbiology). Dr. Marco's work combines systems biology, genetics, and ecology to study microbiomes in food and intestinal systems. Her research has led to over 150 publications, including seminal studies on probiotic mechanisms, fermented food benefits, and gut-microbiota interactions. Notable awards include the American Society for Microbiology Distinguished Lecturer designation (2012–2014), World's Top 2% Scientists recognition (2021–2025), and the 2024 UC Davis Graduate Advising Award. She chairs the Gordon Research Conference on Lactic Acid Bacteria and co-authored the ISAPP consensus statement on fermented foods. Her research group explores topics like bacteriocin activity, microbiota-gut-brain interactions, and food safety innovations. Collaborative projects include studies on Indigenous fermentation practices and microbial electrochemical systems for pathogen detection.

• Immunology
• Molecular Immunology
• T cell biology
• +۵ مورد دیگر

Brigitta Stockinger is a distinguished Professor at the Francis Crick Institute, leading research in the Division of Molecular Immunology. With a career spanning over three decades, she has established herself as a leading authority in immunology, particularly in the study of T cell biology and the aryl hydrocarbon receptor (AHR) pathway. PhD in Biology from the University of Mainz Postdoctoral training in London, Cambridge, and Heidelberg Member of the Basel Institute for Immunology (1985-1991) Group leader at MRC National Institute for Medical Research (1991-present, now part of Francis Crick Institute) Head of Division of Molecular Immunology (2010-present) Professor Stockinger's research has evolved from studying immune tolerance using T cell receptor transgenic mouse models to pioneering work on immunological memory with CD4 memory T cells. Her lab made seminal discoveries regarding Th17 cell differentiation factors, which led to groundbreaking research on the aryl hydrocarbon receptor (AHR) as an environmental sensor in the immune system. Her work spans fundamental immunology, infection responses, inflammation, and the intersection of environmental factors with immune regulation. Analysis of her extensive publication record (over 65 Crick publications) reveals a strong focus on Immunology (38 publications), followed by Model Organisms (12), Genetics & Genomics (10), and Tumour Biology (9). Her most influential work appears in top journals including Nature (5 papers), Nature Immunology (6 papers), and Immunity (6 papers), demonstrating the high impact of her research on understanding T cell plasticity, AHR signaling, and mucosal immunity. Fellow of the Academy of Medical Sciences (2005) EMBO fellow (2008) Fellow of the Royal Society (2013) ERC Advanced Investigator grant (2009) Wellcome Senior Investigator Grant (2013) CRUK grant (2015) Wellcome Investigator Grant (2018) Professor Stockinger's laboratory investigates how environmental factors influence immune responses through the AHR pathway, with particular emphasis on intestinal immunity, inflammation, and host-microbe interactions. Her work has significant implications for understanding inflammatory bowel diseases, infection responses, and the role of dietary components in immune regulation. She has established numerous collaborations across the Francis Crick Institute and maintains active research programs examining AHR's role in both innate and adaptive immunity.

Scott Wilsonمشاهده پروفایل

استادیار

• Biomaterials
• Immunoengineering
• Drug Delivery
• +۴ مورد دیگر

Scott Wilson, PhD, is an Assistant Professor in the Department of Biomedical Engineering at Johns Hopkins University, affiliated with the Translational Tissue Engineering Center. His research focuses on synthesizing immunomodulatory biomaterials to control adaptive immune responses for treating malignancies, infectious diseases, and autoimmune conditions. Key interests include tolerance-inducing therapies, spatial-temporal drug delivery, and nanoparticle formulations. Education: PhD in Chemical Engineering (Bioengineering) from Georgia Institute of Technology (2011) MS in Chemical Engineering from University of Oklahoma (2004) BS in Chemical Engineering from University of Oklahoma (2001) Research Interests: Wilson’s lab develops bespoke biomaterials to bias immune responses toward immunity or tolerance. Projects include cancer immunotherapy via polymeric glyco-adjuvants, allergy suppression through glycoengineered antigens, and antimicrobial coatings for titanium implants. His work bridges organic chemistry and biomedical applications, emphasizing preclinical validation. Collaborative Grants: Wilson contributed to two Johns Hopkins Discovery Awards (2020 and 2024), fostering interdisciplinary projects. His lab collaborates on translational efforts, including gene therapy delivery systems and osseointegration enhancements. Labs & Teams: The Wilson Laboratory for Biomaterials Synthesis and Immunoengineering focuses on engineering immune responses via functional biomaterials. Key themes include antigen-specific tolerance induction and targeted drug delivery platforms.